Journal of Applied Physiology, Vol 66, Issue 4 1685-1693, Copyright © 1989 by American Physiological Society

ARTICLES

Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction

R. C. Beasley, R. L. Featherstone, M. K. Church, P. Rafferty, J. G. Varley, A. Harris, C. Robinson and S. T. Holgate
Immunopharmacology Group, Southampton General Hospital, United Kingdom.

In this study we investigated the effect of the selective and potent thromboxane A2 (TxA2) receptor antagonist GR32191 on smooth muscle contraction induced by the TxA2 analogue U46619, prostaglandin (PG) D2, PGF2 alpha, and methacholine (MCh) in guinea pig airways in vitro and the airways response provoked by inhaled PGD2 and MCh in asthmatic subjects in vivo. GR32191 antagonized competitively the contractile responses of all three prostanoids to a similar degree but had no effect on MCh-induced contractions. In asthmatic subjects GR32191, in a single oral dose of 80 mg, did not affect base-line airway caliber or MCh-induced broncho-constriction but caused significant inhibition of PGD2-induced bronchoconstriction, displacing the concentration-response curves to the right by greater than 10-fold. The effect of the same oral dose of GR32191 on allergen-induced immediate bronchoconstriction was subsequently investigated in allergic asthmatic subjects. In individual subjects, GR32191 inhibited to varying degrees the overall bronchoconstrictor response, with the maximum effect occurring between 10 and 30 min after allergen challenge. These studies suggest that prostanoids contribute to the immediate bronchoconstriction induced by inhaled allergen in allergic asthmatics, and that this effect is mediated by stimulation of a thromboxane receptor.

This article has been cited by other articles:

				J.D. Brannan, M. Gulliksson, S.D. Anderson, N. Chew, and M. Kumlin Evidence of mast cell activation and leukotriene release after mannitol inhalation Eur. Respir. J., September 1, 2003; 22(3): 491 - 496. [Abstract] [Full Text] [PDF]

				A. Wohlsen, C. Martin, E. Vollmer, D. Branscheid, H. Magnussen, W-M. Becker, U. Lepp, and S. Uhlig The early allergic response in small airways of human precision-cut lung slices Eur. Respir. J., June 1, 2003; 21(6): 1024 - 1032. [Abstract] [Full Text] [PDF]

				T. Kohyama, T. A. Wyatt, X. Liu, F.-Q. Wen, T. Kobayashi, Q. Fang, H. J. Kim, and S. I. Rennard PGD2 Modulates Fibroblast-Mediated Native Collagen Gel Contraction Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 375 - 381. [Abstract] [Full Text] [PDF]

				T. Kohyama, X.D. Liu, F.Q. Wen, H.J. Kim, H. Takizawa, and S.I. Rennard Prostaglandin D2 inhibits fibroblast migration Eur. Respir. J., April 1, 2002; 19(4): 684 - 689. [Abstract] [Full Text] [PDF]

				J. Tamaoki, M. Kondo, J. Nakata, Y. Nagano, K. Isono, and A. Nagai Effect of a Thromboxane A2 Antagonist on Sputum Production and Its Physicochemical Properties in Patients With Mild to Moderate Asthma Chest, July 1, 2000; 118(1): 73 - 79. [Abstract] [Full Text] [PDF]

				P. M. O'BYRNE Leukotriene Bronchoconstriction Induced by Allergen and Exercise Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): S68 - 72. [Full Text] [PDF]

				M. FUJIMURA, M. ABO, Y. KAMIO, S. MYOU, Y. ISHIURA, T. HASHIMOTO, and T. MATSUDA Effect of Leukotriene and Thromboxane Antagonist on Propranolol-induced Bronchoconstriction Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 2100 - 2103. [Abstract] [Full Text]

				M. A. Giembycz and M. A. Lindsay Pharmacology of the Eosinophil Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340. [Abstract] [Full Text] [PDF]